Humalog Mix25 Kwikpen (Insulin Lispro)

Humalog Mix25 Kwikpen is indicated for the management of blood glucose in patients with diabetes who need a combination of rapid‑acting insulin for meals and a short‑acting component for basal coverage.

• Type 1 diabetes mellitus requiring mealtime insulin.
• Type 2 diabetes mellitus when oral agents are insufficient.
• Adults who prefer a pre‑filled pen for convenient dosing.
• Patients needing a mixed insulin formulation to simplify injection schedules.
• Use as part of a comprehensive diabetes management plan including diet and exercise.

• Insulin lispro is a rapid‑acting insulin analog that binds to the insulin receptor on cell membranes. Upon binding, it activates the receptor’s intrinsic tyrosine kinase activity, which initiates a cascade that promotes translocation of glucose transporter type 4 (GLUT4) to the cell surface, enhancing glucose uptake in muscle and adipose tissue. The mixed formulation also provides a short‑acting component that contributes to basal insulin levels between meals.

Like other insulin products, Humalog Mix25 Kwikpen may cause adverse reactions, most of which are related to its glucose‑lowering action or injection site.

Common

• Hypoglycemia (low blood glucose)
• Injection‑site redness, swelling, or itching
• Lipodystrophy (fat tissue changes at injection site)
• Weight gain

Serious

• Severe hypoglycemia leading to loss of consciousness
• Allergic reactions such as rash, urticaria, or anaphylaxis
• Edema (swelling of extremities)

Before using Humalog Mix25 Kwikpen, certain precautions should be considered to ensure safe and effective therapy.

• Verify the correct pen and insulin type before each injection.
• Rotate injection sites to reduce the risk of lipodystrophy.
• Adjust dose based on blood glucose monitoring and carbohydrate intake.
• Use caution in patients with renal or hepatic impairment, as insulin clearance may be reduced.
• Do not use if the pen has been dropped, exposed to extreme temperatures, or the solution appears cloudy.
• Pregnant or breastfeeding individuals should consult a healthcare professional.
• Store the pen refrigerated before first use; after opening, keep at room temperature no longer than 28 days.

Humalog Mix25 Kwikpen can interact with other medicines, affecting blood glucose levels or insulin action.

Avoid

• Other rapid‑acting insulins or insulin analogs administered simultaneously.
• Sulfonylureas or meglitinides that increase risk of hypoglycemia.
• Beta‑blockers that may mask hypoglycemia symptoms.

Use with caution

• Oral antihyperglycemics (e.g., metformin, DPP‑4 inhibitors) – monitor glucose closely.
• Corticosteroids – may raise glucose, requiring dose adjustment.
• Diuretics and ACE inhibitors – can affect potassium balance and renal function.
• Alcohol – can cause delayed hypoglycemia.